Inhibitors of RAAS, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), initially developed 3–4 decades ago to treat hypertension, proved to be extremely effective in preventing the onset and progression of DKD, congestive heart failure, and even coronary artery disease. The gene discussed is ACE; the disease is congestive heart failure.